1. Comparative Assessment Of The Time Of Patients’ Stay In The Intensive Care Unit After Mitral Valve Replacement With Preservation Of The Posterior Leaflet And Complete Removal Of Subvalvular Structures

Authors

  • S.A. Zhumabaev Research Institute of Cardiovascular Surgery and Organ Transplantation of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic
  • N.O. Raiapov Research Institute of Cardiovascular Surgery and Organ Transplantation of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic
  • M.I. Asanaliev Research Institute of Cardiovascular Surgery and Organ Transplantation of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic
  • Zh.A. Bkhad Research Institute of Cardiovascular Surgery and Organ Transplantation of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic
  • K.S. Urmanbetov Research Institute of Cardiovascular Surgery and Organ Transplantation of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic
  • G.T. Tursunbekova Research Institute of Cardiovascular Surgery and Organ Transplantation of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic

Downloads

Abstract

The aim is to evaluate the effectiveness of time spent in the intensive care unit and the use of inotropic drugs after mitral valve replacement surgery with preservation of the posterior leaflet with comparison of complete removal of subvalvular structures..

Material and methods. The study included 60 patients, including 28 patients after surgery with pres-ervation of the posterior mitral valve leaflet and 32 patients after surgery with complete removal of subval-vular structures. The average age of the patients was 45.9±12.0 years. Inclusion criteria were the time spent in the intensive care unit after surgery, the use of inotropic drugs, and the duration of use of the ventilator..

Results. In comparison, the control group in the intensive care unit received more inotropic drugs. In the main group of renal doses - 21 (75%) patients received dopamine - 2.38±0.21 micrograms per kilogram minute, adrenaline - 0.021±0.003 micrograms per kilogram minute. Cardiotonics were not received at thera-peutic doses. Above therapeutic doses - 2 (7.14%) patients received (dopamine) - 8±0.01 micrograms per kilogram minute. In the second group of renal doses - 23 (71.87%) patients received dopamine 2.24±0.54 micrograms per kilogram minute, adrenaline - 0.021±0.001 micrograms per kilogram minute. Therapeutic doses of 5 (15.6%) patients dopamine - 5.2±0.4 micrograms per kilogram minute, adrenaline - 0.04±0.001 micrograms per kilogram minute. Above therapeutic doses of 2 (6.25%) patients, dopamine is 8.2±0.02 micrograms per kilogram minute, adrenaline is 0.07±0.003 micrograms per kilogram minute.

Keywords

mitral valve replacement, subval-vular structure, posterior cusp, cardiotonic drugs https://

References

  1. Lawrence H.C., Tchantchaleishvili V., Rajab T.K. Evolution of the concept and practice of mi-tral valve repair. Ann. Cardiothorac. Surg. 2015; 4 (4): 315–321. DOI:10.3978/j.issn.2225-319X.2015.04.09
  2. Nurbay Zh.N., Novikov VK, Gordeev ML Prosthetics of the mitral valve with preservation of subvalvular structures //
  3. Bockeria, L.A. Mitral valve replacement in young children with CHD / L.A. Bockeria, K. V. Shatalov, A. A. Svobodov, T. I. Musatova and others // Tho-racic and cardiovascular surgery. - M., - 2003. -№3.-С.16-19. COMPARATIVE ASSESSMENT OF THE TIME OF PATIENTS’ STAY IN THE INTENSIVE CARE UNIT AFTER MITRAL VALVE REPLACEMENT WITH PRESERVATION OF THE POSTERIOR LEAFLET AND COMPLETE REMOVAL OF SUBVALVULAR STRUCTURES R., Seitahunova E., Toktosunova D. Preservation of the subvalvular apparatus during mitral valve re-placement. International scientific review. 2016; 22 (3): 324–330. 16
  4. Coutinho GF, Bihun V, Correia PE, Antunes PE, An-tunes MJ. Preservation of the subvalvular apparatus during mitral valve replacement of rheumatic valves does not affect long-term survival. //Eur J, Cardio-thorac, Surg. 2015. V. 48 . N6. P. 861-7
  5. Lafci G., Cagli K., Cicek O. F., Korkmaz K., Turak O., Uzun A., Yalcinkaya A., Diken A., Gunertem E. Pap-ilary muscle repositioning as a subvalvular apparatus preservation technique in mitral stenosis patients with normal left ventricular systolic function //Tex Heart Inst J. 2014. V. 41. N1. P. 33-39
  6. Timala RB, Joshi D, Aryal M, Bhandari K, Singh Y, Sharma J. Effects of subvalvular apparatus preser-vation in mitral valve replacement among rheumatic patients: early and mid-term follow up. J Inst Med 2016, 38: 2-3
  7. Toktosunova D. B., Djundubaev M. K., Seytahunova E. D., Ahmedova I. A. Remodeling of the left heart in patients with rheumatic mitral valve disease after mitral valve replacement with preservation of sub-valvular structures // J. Scientific Research Institute of Heart Surg. and Organ Transplantation. 2020. 4. 40-44. COMPARATIVE ASSESSMENT OF THE TIME OF PATIENTS’ STAY IN THE INTENSIVE CARE UNIT AFTER MITRAL VALVE REPLACEMENT WITH PRESERVATION OF THE POSTERIOR LEAFLET AND COMPLETE REMOVAL OF SUBVALVULAR STRUCTURES

Published

2021-12-17

Issue

No. 4 (2021)

Section

Статьи